Literature DB >> 1327117

Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains.

M Okigaki1, M Komada, Y Uehara, K Miyazawa, N Kitamura.   

Abstract

Human hepatocyte growth factor (hHGF) consists of characteristic structural domains. In this study, we prepared mutant proteins lacking each of these domains and examined their biological activities for stimulation of hepatocyte DNA synthesis, inhibition of Meth A cell growth, and induction of MDCK cell dissociation. We also examined their interactions with the c-met/HGF receptor by competition analysis and by analysis of levels of tyrosine phosphorylation. The mutant proteins lacking the N-terminal, the first kringle, or the second kringle domain were not biologically effective and could not compete with hHGF bound to the c-met/HGF receptor. The results indicate that these domains are necessary for the biological activities of hHGF mediated by binding to the c-met/HGF receptor. The mutant proteins lacking the third or fourth kringle domain moderately retained biological activities and the receptor binding. The relative levels of the tyrosine phosphorylation of the c-met/HGF receptor by these mutant proteins correlated well with the relative potencies of the biological activities when compared with that of the wild-type hHGF. The mutant protein lacking the light chain was not effective in the biological activities and tyrosine phosphorylation of the c-met/HGF receptor, but competed with hHGF bound to the c-met/HGF receptor. These results suggest that the heavy chain plays an important role in the interaction of hHGF with the c-met/HGF receptor and that the light chain is further required for the tyrosine phosphorylation of the c-met/HGF receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327117     DOI: 10.1021/bi00155a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Alternative proteolytic processing of hepatocyte growth factor during wound repair.

Authors:  Nils Buchstein; Daniel Hoffmann; Hans Smola; Sabina Lang; Mats Paulsson; Catherin Niemann; Thomas Krieg; Sabine A Eming
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

2.  Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.

Authors:  T Otsuka; J Jakubczak; W Vieira; D P Bottaro; D Breckenridge; W J Larochelle; G Merlino
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).

Authors:  L E Donate; E Gherardi; N Srinivasan; R Sowdhamini; S Aparicio; T L Blundell
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

4.  Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.

Authors:  Fabiola Cecchi; Deborah Pajalunga; C Andrew Fowler; Aykut Uren; Daniel C Rabe; Benedetta Peruzzi; Nicholas J Macdonald; Davida K Blackman; Stephen J Stahl; R Andrew Byrd; Donald P Bottaro
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

5.  Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells.

Authors:  Kevin J Church; Brett R Vanderwerff; Rachelle R Riggers; Michelle D McMicheal; Beatriz Mateo-Victoriano; Sudharsan R Sukumar; Joseph W Harding
Journal:  Anticancer Drugs       Date:  2016-09       Impact factor: 2.248

6.  Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy.

Authors:  Kari Nejak-Bowen; Anne Orr; William C Bowen; George K Michalopoulos
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

Review 7.  Achieving high signal-to-noise in cell regulatory systems: Spatial organization of multiprotein transmembrane assemblies of FGFR and MET receptors.

Authors:  Michal Blaszczyk; Nicholas J Harmer; Dimitri Y Chirgadze; David B Ascher; Tom L Blundell
Journal:  Prog Biophys Mol Biol       Date:  2015-05-05       Impact factor: 3.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.